HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NELL-1 in the treatment of osteoporotic bone loss.

Abstract
NELL-1 is a secreted, osteoinductive protein whose expression rheostatically controls skeletal ossification. Overexpression of NELL-1 results in craniosynostosis in humans and mice, whereas lack of Nell-1 expression is associated with skeletal undermineralization. Here we show that Nell-1-haploinsufficient mice have normal skeletal development but undergo age-related osteoporosis, characterized by a reduction in osteoblast:osteoclast (OB:OC) ratio and increased bone fragility. Recombinant NELL-1 binds to integrin β1 and consequently induces Wnt/β-catenin signalling, associated with increased OB differentiation and inhibition of OC-directed bone resorption. Systemic delivery of NELL-1 to mice with gonadectomy-induced osteoporosis results in improved bone mineral density. When extended to a large animal model, local delivery of NELL-1 to osteoporotic sheep spine leads to significant increase in bone formation. Altogether, these findings suggest that NELL-1 deficiency plays a role in osteoporosis and demonstrate the potential utility of NELL-1 as a combination anabolic/antiosteoclastic therapeutic for bone loss.
AuthorsAaron W James, Jia Shen, Xinli Zhang, Greg Asatrian, Raghav Goyal, Jin H Kwak, Lin Jiang, Benjamin Bengs, Cymbeline T Culiat, A Simon Turner, Howard B Seim Iii, Benjamin M Wu, Karen Lyons, John S Adams, Kang Ting, Chia Soo
JournalNature communications (Nat Commun) Vol. 6 Pg. 7362 (Jun 17 2015) ISSN: 2041-1723 [Electronic] England
PMID26082355 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Calcium-Binding Proteins
  • Integrin beta Chains
  • NELL1 protein, human
  • Nerve Tissue Proteins
  • Wnt Proteins
  • beta Catenin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Bone and Bones (pathology)
  • Calcium-Binding Proteins
  • Cells, Cultured
  • Drug Evaluation, Preclinical
  • Female
  • Haploinsufficiency
  • Humans
  • Integrin beta Chains (metabolism)
  • Male
  • Mice
  • Middle Aged
  • Nerve Tissue Proteins (administration & dosage, deficiency)
  • Osteoporosis (drug therapy, etiology, metabolism, pathology)
  • Phenotype
  • Sheep
  • Wnt Proteins (metabolism)
  • Young Adult
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: